Evoq Remedies Ltd — Others, 03-06-2025: AGM/EGM

Evoq Remedies Limited has announced the outcome of its Extra-Ordinary General Meeting held via video conferencing. Key approvals sought included an increase in authorised share capital, alteration of the capital clause in the Memorandum of Association, issuance of equity shares on a preferential basis (other than cash), and alteration of the object clause in the Memorandum of Association. Voting concluded promptly with provisions for remote e-voting, and final results will be announced within two working days. These changes could support Evoq Remedies’ capital restructuring and future growth plans, important for shareholders tracking its strategic moves.